Efficacy of Certolizumab Pegol for Psoriasis of the Head and Neck in Two Phase 3 Clinical Trials: CIMPASI-1 and CIMPASI-2. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 3, p. S40, 2019. DOI: 10.25251/skin.3.supp.40. Disponível em: https://skin.dermsquared.com/skin/article/view/767. Acesso em: 19 apr. 2025.